CJ 14199Alternative Names: CJ-14199
Latest Information Update: 02 Dec 2015
Price : $50
At a glance
- Originator CJ Cheiljedang Corp.
- Developer CJ HealthCare
- Mechanism of Action Sodium-bile acid cotransporter-inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Constipation; Irritable bowel syndrome